aluates Reports

$ 0.0

Automative

Albendazole - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: April 2024

Report Code: QYRE-Auto-21Y9079

BUY CHAPTERS

Albendazole - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-21Y9079

Report

April 2024

Pages:123

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GlaxoSmithKline PLC

Huazhong Pharmaceutical

Jiangsu Qihui

Sequent Scientific

K.A.Malle Pharmaceuticals

Lasa Supergenerics Limited

Zhongjia Pharmaceutical

Fredun Pharmaceuticals Ltd

Supharma Chem

Salius Pharma

Albendazole - Market Size

The global market for Albendazole was estimated to be worth US$ 159.1 million in 2023 and is forecast to a readjusted size of US$ 270.8 million by 2030 with a CAGR of 7.8% during the forecast period 2024-2030

Albendazole - Market

Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.

This is a relatively concentrated market, mainly due to the particularity of the pharmaceutical industry, where there are higher operating licenses and barriers, technical barriers, capital barriers and environmental barriers, so the concentration is higher. From the perspective of the global market, the original research firm GSK's albendazole accounts for more than 40% of the entire industry and is the leading enterprise in the albendazole industry. From the perspective of the Chinese market, the market concentration is also relatively high. The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Albendazole, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Albendazole by region & country, by Type, and by Application.

The Albendazole market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albendazole.

Market Segmentation

Scope of Albendazole - Market Report

Report Metric	Details
Report Name	Albendazole - Market
Forecasted market size in 2030	US$ 270.8 million
CAGR	7.8%
Forecasted years	2024 - 2030
Segment by Type:	Tablet Capsule Other
Segment by Application	Human Veterinary
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Huazhong Pharmaceutical, Jiangsu Qihui, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Zhongjia Pharmaceutical, Fredun Pharmaceuticals Ltd, Supharma Chem, Salius Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Albendazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Albendazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Albendazole in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Albendazole - Market size in 2030?

Ans: The Albendazole - Market size in 2030 will be US$ 270.8 million.

What is the Huazhong Pharmaceutical, Jiangsu Qihui share in Albendazole - Market?

Ans: The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.

Who are the main players in the Albendazole - Market report?

Ans: The main players in the Albendazole - Market are GlaxoSmithKline, Huazhong Pharmaceutical, Jiangsu Qihui, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Zhongjia Pharmaceutical, Fredun Pharmaceuticals Ltd, Supharma Chem, Salius Pharma

What are the Application segmentation covered in the Albendazole - Market report?

Ans: The Applications covered in the Albendazole - Market report are Human, Veterinary

What are the Type segmentation covered in the Albendazole - Market report?

Ans: The Types covered in the Albendazole - Market report are Tablet, Capsule, Other

1 Market Overview

1.1 Albendazole Product Introduction

1.2 Global Albendazole Market Size Forecast

1.2.1 Global Albendazole Sales Value (2019-2030)

1.2.2 Global Albendazole Sales Volume (2019-2030)

1.2.3 Global Albendazole Sales Price (2019-2030)

1.3 Albendazole Market Trends & Drivers

1.3.1 Albendazole Industry Trends

1.3.2 Albendazole Market Drivers & Opportunity

1.3.3 Albendazole Market Challenges

1.3.4 Albendazole Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Albendazole Players Revenue Ranking (2023)

2.2 Global Albendazole Revenue by Company (2019-2024)

2.3 Global Albendazole Players Sales Volume Ranking (2023)

2.4 Global Albendazole Sales Volume by Company Players (2019-2024)

2.5 Global Albendazole Average Price by Company (2019-2024)

2.6 Key Manufacturers Albendazole Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Albendazole Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Albendazole

2.9 Albendazole Market Competitive Analysis

2.9.1 Albendazole Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Albendazole Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albendazole as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Tablet

3.1.2 Capsule

3.1.3 Other

3.2 Global Albendazole Sales Value by Type

3.2.1 Global Albendazole Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Albendazole Sales Value, by Type (2019-2030)

3.2.3 Global Albendazole Sales Value, by Type (%) (2019-2030)

3.3 Global Albendazole Sales Volume by Type

3.3.1 Global Albendazole Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Albendazole Sales Volume, by Type (2019-2030)

3.3.3 Global Albendazole Sales Volume, by Type (%) (2019-2030)

3.4 Global Albendazole Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Human

4.1.2 Veterinary

4.2 Global Albendazole Sales Value by Application

4.2.1 Global Albendazole Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Albendazole Sales Value, by Application (2019-2030)

4.2.3 Global Albendazole Sales Value, by Application (%) (2019-2030)

4.3 Global Albendazole Sales Volume by Application

4.3.1 Global Albendazole Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Albendazole Sales Volume, by Application (2019-2030)

4.3.3 Global Albendazole Sales Volume, by Application (%) (2019-2030)

4.4 Global Albendazole Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Albendazole Sales Value by Region

5.1.1 Global Albendazole Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Albendazole Sales Value by Region (2019-2024)

5.1.3 Global Albendazole Sales Value by Region (2025-2030)

5.1.4 Global Albendazole Sales Value by Region (%), (2019-2030)

5.2 Global Albendazole Sales Volume by Region

5.2.1 Global Albendazole Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Albendazole Sales Volume by Region (2019-2024)

5.2.3 Global Albendazole Sales Volume by Region (2025-2030)

5.2.4 Global Albendazole Sales Volume by Region (%), (2019-2030)

5.3 Global Albendazole Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Albendazole Sales Value, 2019-2030

5.4.2 North America Albendazole Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Albendazole Sales Value, 2019-2030

5.5.2 Europe Albendazole Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Albendazole Sales Value, 2019-2030

5.6.2 Asia Pacific Albendazole Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Albendazole Sales Value, 2019-2030

5.7.2 South America Albendazole Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Albendazole Sales Value, 2019-2030

5.8.2 Middle East & Africa Albendazole Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Albendazole Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Albendazole Sales Value

6.2.1 Key Countries/Regions Albendazole Sales Value, 2019-2030

6.2.2 Key Countries/Regions Albendazole Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Albendazole Sales Value, 2019-2030

6.3.2 United States Albendazole Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Albendazole Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Albendazole Sales Value, 2019-2030

6.4.2 Europe Albendazole Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Albendazole Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Albendazole Sales Value, 2019-2030

6.5.2 China Albendazole Sales Value by Type (%), 2023 VS 2030

6.5.3 China Albendazole Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Albendazole Sales Value, 2019-2030

6.6.2 Japan Albendazole Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Albendazole Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Albendazole Sales Value, 2019-2030

6.7.2 South Korea Albendazole Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Albendazole Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Albendazole Sales Value, 2019-2030

6.8.2 Southeast Asia Albendazole Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Albendazole Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Albendazole Sales Value, 2019-2030

6.9.2 India Albendazole Sales Value by Type (%), 2023 VS 2030

6.9.3 India Albendazole Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 GlaxoSmithKline

7.1.1 GlaxoSmithKline Company Information

7.1.2 GlaxoSmithKline Introduction and Business Overview

7.1.3 GlaxoSmithKline Albendazole Sales, Revenue and Gross Margin (2019-2024)

7.1.4 GlaxoSmithKline Albendazole Product Offerings

7.1.5 GlaxoSmithKline Recent Development

7.2 Huazhong Pharmaceutical

7.2.1 Huazhong Pharmaceutical Company Information

7.2.2 Huazhong Pharmaceutical Introduction and Business Overview

7.2.3 Huazhong Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Huazhong Pharmaceutical Albendazole Product Offerings

7.2.5 Huazhong Pharmaceutical Recent Development

7.3 Jiangsu Qihui

7.3.1 Jiangsu Qihui Company Information

7.3.2 Jiangsu Qihui Introduction and Business Overview

7.3.3 Jiangsu Qihui Albendazole Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Jiangsu Qihui Albendazole Product Offerings

7.3.5 Jiangsu Qihui Recent Development

7.4 Sequent Scientific

7.4.1 Sequent Scientific Company Information

7.4.2 Sequent Scientific Introduction and Business Overview

7.4.3 Sequent Scientific Albendazole Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Sequent Scientific Albendazole Product Offerings

7.4.5 Sequent Scientific Recent Development

7.5 K.A. Malle Pharmaceuticals

7.5.1 K.A. Malle Pharmaceuticals Company Information

7.5.2 K.A. Malle Pharmaceuticals Introduction and Business Overview

7.5.3 K.A. Malle Pharmaceuticals Albendazole Sales, Revenue and Gross Margin (2019-2024)

7.5.4 K.A. Malle Pharmaceuticals Albendazole Product Offerings

7.5.5 K.A. Malle Pharmaceuticals Recent Development

7.6 Lasa Supergenerics Limited

7.6.1 Lasa Supergenerics Limited Company Information

7.6.2 Lasa Supergenerics Limited Introduction and Business Overview

7.6.3 Lasa Supergenerics Limited Albendazole Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Lasa Supergenerics Limited Albendazole Product Offerings

7.6.5 Lasa Supergenerics Limited Recent Development

7.7 Zhongjia Pharmaceutical

7.7.1 Zhongjia Pharmaceutical Company Information

7.7.2 Zhongjia Pharmaceutical Introduction and Business Overview

7.7.3 Zhongjia Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Zhongjia Pharmaceutical Albendazole Product Offerings

7.7.5 Zhongjia Pharmaceutical Recent Development

7.8 Fredun Pharmaceuticals Ltd

7.8.1 Fredun Pharmaceuticals Ltd Company Information

7.8.2 Fredun Pharmaceuticals Ltd Introduction and Business Overview

7.8.3 Fredun Pharmaceuticals Ltd Albendazole Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Fredun Pharmaceuticals Ltd Albendazole Product Offerings

7.8.5 Fredun Pharmaceuticals Ltd Recent Development

7.9 Supharma Chem

7.9.1 Supharma Chem Company Information

7.9.2 Supharma Chem Introduction and Business Overview

7.9.3 Supharma Chem Albendazole Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Supharma Chem Albendazole Product Offerings

7.9.5 Supharma Chem Recent Development

7.10 Salius Pharma

7.10.1 Salius Pharma Company Information

7.10.2 Salius Pharma Introduction and Business Overview

7.10.3 Salius Pharma Albendazole Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Salius Pharma Albendazole Product Offerings

7.10.5 Salius Pharma Recent Development

8 Industry Chain Analysis

8.1 Albendazole Industrial Chain

8.2 Albendazole Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Albendazole Sales Model

8.5.2 Sales Channel

8.5.3 Albendazole Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

GlaxoSmithKline PLC

Huazhong Pharmaceutical

Jiangsu Qihui

Sequent Scientific

K.A.Malle Pharmaceuticals

Lasa Supergenerics Limited

Zhongjia Pharmaceutical

Fredun Pharmaceuticals Ltd

Supharma Chem

Salius Pharma

List of Tables

Table 1. Albendazole Market Trends

Table 2. Albendazole Market Drivers & Opportunity

Table 3. Albendazole Market Challenges

Table 4. Albendazole Market Restraints

Table 5. Global Albendazole Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Albendazole Revenue Market Share by Company (2019-2024)

Table 7. Global Albendazole Sales Volume by Company (2019-2024) & (K MT)

Table 8. Global Albendazole Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Albendazole Price by Company (2019-2024) & (USD/MT)

Table 10. Key Manufacturers Albendazole Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Albendazole Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Albendazole

Table 13. Global Albendazole Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albendazole as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Albendazole Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Albendazole Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Albendazole Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Albendazole Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Albendazole Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Albendazole Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)

Table 22. Global Albendazole Sales Volume by Type (2019-2024) & (K MT)

Table 23. Global Albendazole Sales Volume by Type (2025-2030) & (K MT)

Table 24. Global Albendazole Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Albendazole Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Albendazole Price by Type (2019-2024) & (USD/MT)

Table 27. Global Albendazole Price by Type (2025-2030) & (USD/MT)

Table 28. Global Albendazole Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Albendazole Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Albendazole Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Albendazole Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Albendazole Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Albendazole Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)

Table 34. Global Albendazole Sales Volume by Application (2019-2024) & (K MT)

Table 35. Global Albendazole Sales Volume by Application (2025-2030) & (K MT)

Table 36. Global Albendazole Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Albendazole Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Albendazole Price by Application (2019-2024) & (USD/MT)

Table 39. Global Albendazole Price by Application (2025-2030) & (USD/MT)

Table 40. Global Albendazole Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Albendazole Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Albendazole Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Albendazole Sales Value by Region (2019-2024) & (%)

Table 44. Global Albendazole Sales Value by Region (2025-2030) & (%)

Table 45. Global Albendazole Sales Volume by Region (K MT): 2019 VS 2023 VS 2030

Table 46. Global Albendazole Sales Volume by Region (2019-2024) & (K MT)

Table 47. Global Albendazole Sales Volume by Region (2025-2030) & (K MT)

Table 48. Global Albendazole Sales Volume by Region (2019-2024) & (%)

Table 49. Global Albendazole Sales Volume by Region (2025-2030) & (%)

Table 50. Global Albendazole Average Price by Region (2019-2024) & (USD/MT)

Table 51. Global Albendazole Average Price by Region (2025-2030) & (USD/MT)

Table 52. Key Countries/Regions Albendazole Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Albendazole Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Albendazole Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Albendazole Sales Volume, (2019-2024) & (K MT)

Table 56. Key Countries/Regions Albendazole Sales Volume, (2025-2030) & (K MT)

Table 57. GlaxoSmithKline Company Information

Table 58. GlaxoSmithKline Introduction and Business Overview

Table 59. GlaxoSmithKline Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 60. GlaxoSmithKline Albendazole Product Offerings

Table 61. GlaxoSmithKline Recent Development

Table 62. Huazhong Pharmaceutical Company Information

Table 63. Huazhong Pharmaceutical Introduction and Business Overview

Table 64. Huazhong Pharmaceutical Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 65. Huazhong Pharmaceutical Albendazole Product Offerings

Table 66. Huazhong Pharmaceutical Recent Development

Table 67. Jiangsu Qihui Company Information

Table 68. Jiangsu Qihui Introduction and Business Overview

Table 69. Jiangsu Qihui Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 70. Jiangsu Qihui Albendazole Product Offerings

Table 71. Jiangsu Qihui Recent Development

Table 72. Sequent Scientific Company Information

Table 73. Sequent Scientific Introduction and Business Overview

Table 74. Sequent Scientific Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 75. Sequent Scientific Albendazole Product Offerings

Table 76. Sequent Scientific Recent Development

Table 77. K.A. Malle Pharmaceuticals Company Information

Table 78. K.A. Malle Pharmaceuticals Introduction and Business Overview

Table 79. K.A. Malle Pharmaceuticals Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 80. K.A. Malle Pharmaceuticals Albendazole Product Offerings

Table 81. K.A. Malle Pharmaceuticals Recent Development

Table 82. Lasa Supergenerics Limited Company Information

Table 83. Lasa Supergenerics Limited Introduction and Business Overview

Table 84. Lasa Supergenerics Limited Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 85. Lasa Supergenerics Limited Albendazole Product Offerings

Table 86. Lasa Supergenerics Limited Recent Development

Table 87. Zhongjia Pharmaceutical Company Information

Table 88. Zhongjia Pharmaceutical Introduction and Business Overview

Table 89. Zhongjia Pharmaceutical Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 90. Zhongjia Pharmaceutical Albendazole Product Offerings

Table 91. Zhongjia Pharmaceutical Recent Development

Table 92. Fredun Pharmaceuticals Ltd Company Information

Table 93. Fredun Pharmaceuticals Ltd Introduction and Business Overview

Table 94. Fredun Pharmaceuticals Ltd Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 95. Fredun Pharmaceuticals Ltd Albendazole Product Offerings

Table 96. Fredun Pharmaceuticals Ltd Recent Development

Table 97. Supharma Chem Company Information

Table 98. Supharma Chem Introduction and Business Overview

Table 99. Supharma Chem Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 100. Supharma Chem Albendazole Product Offerings

Table 101. Supharma Chem Recent Development

Table 102. Salius Pharma Company Information

Table 103. Salius Pharma Introduction and Business Overview

Table 104. Salius Pharma Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 105. Salius Pharma Albendazole Product Offerings

Table 106. Salius Pharma Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Albendazole Downstream Customers

Table 110. Albendazole Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Albendazole Product Picture

Figure 2. Global Albendazole Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Albendazole Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Albendazole Sales Volume (2019-2030) & (K MT)

Figure 5. Global Albendazole Sales Price (2019-2030) & (USD/MT)

Figure 6. Albendazole Report Years Considered

Figure 7. Global Albendazole Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Albendazole Players Sales Volume Ranking (2023) & (K MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Albendazole Revenue in 2023

Figure 10. Albendazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Tablet Picture

Figure 12. Capsule Picture

Figure 13. Other Picture

Figure 14. Global Albendazole Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Albendazole Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Albendazole Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)

Figure 17. Global Albendazole Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Albendazole Price by Type (2019-2030) & (USD/MT)

Figure 19. Product Picture of Human

Figure 20. Product Picture of Veterinary

Figure 21. Global Albendazole Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Albendazole Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Albendazole Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)

Figure 24. Global Albendazole Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Albendazole Price by Application (2019-2030) & (USD/MT)

Figure 26. North America Albendazole Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Albendazole Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Albendazole Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Albendazole Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Albendazole Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Albendazole Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Albendazole Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Albendazole Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Albendazole Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Albendazole Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Albendazole Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Albendazole Sales Volume (%), (2019-2030)

Figure 38. United States Albendazole Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Albendazole Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Albendazole Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Albendazole Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Albendazole Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Albendazole Sales Value by Application (%), 2023 VS 2030

Figure 44. China Albendazole Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Albendazole Sales Value by Type (%), 2023 VS 2030

Figure 46. China Albendazole Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Albendazole Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Albendazole Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Albendazole Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Albendazole Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Albendazole Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Albendazole Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Albendazole Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Albendazole Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Albendazole Sales Value by Application (%), 2023 VS 2030

Figure 56. India Albendazole Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Albendazole Sales Value by Type (%), 2023 VS 2030

Figure 58. India Albendazole Sales Value by Application (%), 2023 VS 2030

Figure 59. Albendazole Industrial Chain

Figure 60. Albendazole Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions